Literature DB >> 34636044

A medicinal chemist who reshaped the antiviral drug industry: John Charles Martin (1951-2021).

Guangdi Li1, Erik De Clercq2.   

Abstract

John Charles Martin should be remembered as a visionary medicinal chemist who was involved in the coinvention, development, or management of many FDA-approved antiviral drugs such as ganciclovir, stavudine, didanosine, cidofovir, oseltamivir, adefovir dipivoxil, tenofovir disoproxil fumarate, tenofovir alafenamide, sofosbuvir, and remdesivir.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  antiviral industry; medicinal chemisty; obituary

Mesh:

Substances:

Year:  2021        PMID: 34636044     DOI: 10.1002/med.21858

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  3 in total

1.  Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19.

Authors:  Xixi Jing; Min Xu; Deye Song; Tingting Yue; Yali Wang; Pan Zhang; Yanjun Zhong; Min Zhang; Tommy Tsan-Yuk Lam; Nuno Rodrigues Faria; Erik De Clercq; Guangdi Li
Journal:  Immun Ageing       Date:  2022-03-05       Impact factor: 6.400

Review 2.  Approved HIV reverse transcriptase inhibitors in the past decade.

Authors:  Guangdi Li; Yali Wang; Erik De Clercq
Journal:  Acta Pharm Sin B       Date:  2021-11-16       Impact factor: 14.903

3.  Gender disparity and temporal trend of liver cancer in China from 1990 to 2019 and predictions in a 25-year period.

Authors:  Tingting Yue; Ming Xu; Ting Cai; Haizhen Zhu; Mahmoud Reza Pourkarim; Erik De Clercq; Guangdi Li
Journal:  Front Public Health       Date:  2022-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.